MCM
RVMD icon

Moore Capital Management’s Revolution Medicines RVMD Stock Holding History

Moore Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.41M Hold
55,600
– – 0.2% 147
2025
Q4 		$4.43M Hold
55,600
– – 0.09% 274
2025
Q3 		$2.6M Hold
55,600
– – 0.05% 328
2025
Q2 		$2.05M Hold
55,600
– – 0.04% 325
2025
Q1 		$1.97M Hold
55,600
– – 0.07% 268
2024
Q4 		$2.43M Hold
55,600
– – 0.05% 308
2024
Q3 		$2.52M Hold
55,600
– – 0.07% 281
2024
Q2 		$2.16M Hold
55,600
– – 0.05% 265
2024
Q1 		$1.79M Hold
55,600
– – 0.04% 272
2023
Q4 		$1.59M Buy
+55,600
New +$1.34M 0.04% 246

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return